Vita Life Sciences (ASX:VLS) Inventory Turnover: 1.21 (As of Dec. 2025)

What is Vita Life Sciences Inventory Turnover?

Vita Life Sciences ASX:VLS -2.00% 85 Inventory Turnover is 1.21 as of Dec. 2025. GuruFocus rates ASX:VLS with a GF Score™ of 85/100 and a GF Value™ of A$2.48 (Fairly Valued). The stock has 1 warning sign investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Vita Life Sciences's Cost of Goods Sold for the six months ended in Dec. 2025 was A$18.08 Mil. Vita Life Sciences's Average Total Inventories for the quarter that ended in Dec. 2025 was A$14.88 Mil. Vita Life Sciences's Inventory Turnover for the quarter that ended in Dec. 2025 was 1.21.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Vita Life Sciences's Days Inventory for the six months ended in Dec. 2025 was 150.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Vita Life Sciences's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.31.

Vita Life Sciences (ASX:VLS) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Vita Life Sciences's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	14.884	/	18.08	*	365 / 2
	=	150.24

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Vita Life Sciences's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	14.884	/	47.726
	=	0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Vita Life Sciences Inventory Turnover Related Terms

Vita Life Sciences Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Vita Life Sciences's Inventory Turnover can be seen below:

Vita Life Sciences Inventory Turnover Chart

Vita Life Sciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

2.42

2.03

2.34

2.33

2.29

Vita Life Sciences Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Inventory Turnover	Get a 7-Day Free Trial															1.33	1.27	1.01	1.16	1.21

85GF Score

Vita Life Sciences Ltd ASX:VLS

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Vita Life Sciences Inventory Turnover Calculation

Vita Life Sciences's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	36.234	/ (	(16.599	+	15.076)	/	2 )
=	36.234	/	15.8375
=	2.29

Vita Life Sciences's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Jun. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	18.08	/ (	(14.692	+	15.076)	/	2 )
=	18.08	/	14.884
=	1.21

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 1.21 mean?

Vita Life Sciences (ASX:VLS) has a Inventory Turnover of 1.21 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Vita Life Sciences and its competitors.

Is Vita Life Sciences' Inventory Turnover too high?

Vita Life Sciences' current Inventory Turnover is 1.21. Overall, Vita Life Sciences has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Vita Life Sciences' Inventory Turnover compare to ZTS?

Vita Life Sciences' Inventory Turnover of 1.21 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Vita Life Sciences and its competitors. Vita Life Sciences's current Inventory Turnover is 1.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vita Life Sciences stock overvalued right now?

Based on GuruFocus' analysis, Vita Life Sciences (ASX:VLS) is currently considered Fairly Valued. The stock's GF Value™ is A$2.48, compared to a current price of A$2.45 — trading 1.2% below its estimated fair value. The current Inventory Turnover is 1.21. Vita Life Sciences' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Vita Life Sciences (ASX:VLS), the current Inventory Turnover is 1.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vita Life Sciences (ASX:VLS) Overvalued in 2026?

Based on GuruFocus' analysis, Vita Life Sciences stock appears to be undervalued. The current stock price of A$2.45 is trading 1.2% below its estimated GF Value™ of A$2.48. GuruFocus considers Vita Life Sciences to be Fairly Valued.

Key valuation signals for ASX:VLS:

Inventory Turnover: 1.21
GF Value™: A$2.48 vs. price of A$2.45 (1.2% below fair value)
GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the ASX:VLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vita Life Sciences Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies ASX:SNT ASX:MVP ASX:LGP ASX:VIT ASX:PKP ASX:IDT ASX:EPN ASX:ECS ASX:PER ASX:CAN XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Address 1-5 Chalmers Crescent, Suite 802, Level 8, Mascot, Sydney, NSW, AUS, 2020

Website https://www.vitalifesciences.com

Vita Life Sciences Ltd is an Australian-based pharmaceutical and healthcare company involved in formulating, packaging, selling, and distributing vitamins and supplements. It produces a wide range of premium supplements, vitamins, minerals, herbs, and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, VitaScience, and Herbs of Gold brands throughout the Asia-Pacific region. Vita Life Sciences has two operating segments: VMS Operational, which generates maximum revenue, and VMS Investments. Geographically, the Group generates maximum revenue from Malaysia and Singapore, and the rest from Australia, and China and Vietnam.

85GF Score

Get the complete analysis for ASX:VLS

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.45

Price

A$2.48

GF Value

View ASX:VLS Analysis

See Inventory Turnover data for all stocks →